Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro

Demirci, Selami; Dogan, Aysegul; BAŞAK TÜRKMEN, NEŞE; TELCİ, DİLEK; Rizvanov, Albert; ŞAHİN, FİKRETTİN

doi:10.1016/j.biopha.2016.11.101

Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro

Atıf İçin Kopyala

Demirci S., Dogan A., BAŞAK TÜRKMEN N. , TELCİ D., Rizvanov A. A. , ŞAHİN F.

BIOMEDICINE & PHARMACOTHERAPY, cilt.86, ss.492-501, 2017 (SCI İndekslerine Giren Dergi)

Cilt numarası: 86
Basım Tarihi: 2017
Doi Numarası: 10.1016/j.biopha.2016.11.101
Dergi Adı: BIOMEDICINE & PHARMACOTHERAPY
Sayfa Sayıları: ss.492-501

Özet

Prostate cancer is a multistep and complicated cancer type that is regulated by androgens at the cellular level and remains the second commonest cause of death among men. Discovery and development of novel chemotherapeutic agents enabling rapid tumor cell death with minimal toxic effects to healthy tissues might greatly improve the safety of chemotherapy.